Cancer Drivers in the Dark Genome
A new tool for identifying cancer driver mutations in noncoding DNA
Michael Schubert | | Quick Read
Only 2 percent of the human genome encodes proteins; the remaining 98 percent is a mystery – and one we are just beginning to unravel. Evidence increasingly shows that noncoding DNA may be involved in gene regulation, including in cancer formation. But how can we plumb the depths of the noncoding genome? A new computational tool, cis-expression, may offer a solution (1).
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.